Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapies
Lars Masanneck(Hasso Plattner Institute), Marc Pawlitzki(University Hospital Münster), Liesa Regner-Nelke(Heinrich Heine University Düsseldorf), Saskia Räuber(University of Münster), Stefan Bittner(University of Würzburg), Tobias Ruck(University Hospital Münster), Falk Steffen(Johannes Gutenberg University Mainz), Hans‐Peter Hartung(The University of Sydney), Alice Willison(Düsseldorf University Hospital), Frauke Zipp(Institute of Neuroimmunology of the Slovak Academy of Sciences), Philipp Albrecht(Heinrich Heine University Düsseldorf), Leoni Rolfes(University Hospital Münster), Sven G. Meuth(University of Würzburg)
Cited by 21
Related Papers
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Effects of dimethyl fumarate on neuroprotection and immunomodulation
|Journal of Neuroinflammation|2012|223
APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies
|Neurology|2021|217